Related Experiment Video

Updated: Feb 4, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

7.6K

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C

Takahiro Suda1, Tomohide Tatsumi1, Akira Nishio1

  • 1Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan.

Hepatology Communications
|October 6, 2018
PubMed

Insights

Carcinoembryonic antigen-related cell-adhesion molecule 1 (CEACAM1) is elevated in chronic hepatitis C (CHC) and suppresses natural killer (NK) cell function. This study reveals CEACAM1

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Natural killer (NK) cells are crucial for controlling chronic hepatitis C (CHC) and preventing liver cancer.
  • NK cell dysfunction contributes to persistent hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC).
  • The precise mechanisms of NK cell suppression in CHC remain unclear.

Purpose of the Study:

  • To investigate the role of carcinoembryonic antigen-related cell-adhesion molecule 1 (CEACAM1) in suppressing NK cell function during HCV infection.
  • To analyze the impact of CEACAM1 on NK cell activity in the context of CHC pathogenesis.

Main Methods:

  • In vitro studies using Huh7.5.1 cells and the HCV JFH-1 strain to assess CEACAM1 function.
  • Analysis of serum CEACAM1 levels, NK cell function (cytotoxicity, CD107a expression), and CEACAM1 mRNA in human liver samples from CHC patients and controls.
  • Investigating CEACAM1 induction by the HCV E2 glycoprotein.

Main Results:

  • HCV infection increased CEACAM1 expression on hepatocytes (cell surface and mRNA) and in serum.
  • HCV-induced CEACAM1 significantly suppressed NK cell cytotoxicity.
  • Elevated serum CEACAM1 levels in CHC patients correlated with reduced NK cell degranulation (CD107a expression).
  • CEACAM1 expression was higher in HCV-infected liver tissues.

Conclusions:

  • Hepatocellular CEACAM1 expression is induced by HCV infection, leading to impaired NK cell cytotoxicity.
  • CEACAM1 plays a significant role in the pathogenesis of CHC and the progression of hepatocellular carcinoma.

More Related Videos

Analysis of Human Natural Killer Cell Metabolism09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

7.4K
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

19.5K

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
201
What is Natural Selection?01:32

What is Natural Selection?

Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
245